B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways

Molecular Immunology

Volumn 46, Issue 4, 2009, Pages 587-591

  Guo, Benchang ^a   Tumang, Joseph R ^a   Rothstein, Thomas L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

B cells; Cell activation; Signal transduction

Indexed keywords

B LYMPHOCYTE RECEPTOR; BREAKPOINT CLUSTER REGION PROTEIN; CYTOKINE; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 4; OSTEOPONTIN; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OSTEOPONTIN; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

EID: 58249097206     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.029     Document Type: Article

References (32)

1. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., and Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287 (2000) 860-864
2. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
3. Chan V.W., Meng F., Soriano P., DeFranco A.L., and Lowell C.A. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7 (1997) 69-81
4. Chiles T.C., Liu J.L., and Rothstein T.L. Cross-linking of surface Ig receptors on murine B lymphocytes stimulates the expression of nuclear tetradecanoyl phorbol acetate-response element-binding proteins. J. Immunol. 146 (1991) 1730-1735
5. Comabella M., Pericot I., Goertsches R., Nos C., Castillo M., Blas Navarro J., Rio J., and Montalban X. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol. 158 (2005) 231-239
6. Forton A.C., Petri M.A., Goldman D., and Sullivan K.E. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum. Mutat. 19 (2002) 459
7. Fruman D.A., Satterthwaite A.B., and Witte O.N. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13 (2000) 1-3
8. Guo B., Blair D., Chiles T.C., Lowell C.A., and Rothstein T.L. Cutting edge: B cell receptor (BCR) cross-talk: the IL-4-induced alternate pathway for BCR signaling operates in parallel with the classical pathway, is sensitive to Rottlerin, and depends on Lyn. J. Immunol. 178 (2007) 4726-4730
9. Guo B., and Rothstein T.L. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent. J. Immunol. 174 (2005) 5375-5381
10. Hudkins K.L., Giachelli C.M., Eitner F., Couser W.G., Johnson R.J., and Alpers C.E. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int. 57 (2000) 105-116
11. Huo L., and Rothstein T.L. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154 (1995) 3300-3309
12. Iizuka J., Katagiri Y., Tada N., Murakami M., Ikeda T., Sato M., Hirokawa K., Okada S., Hatano M., Tokuhisa T., and Uede T. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab. Invest. 78 (1998) 1523-1533
13. Jansson M., Panoutsakopoulou V., Baker J., Klein L., and Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 168 (2002) 2096-2099
14. Lampe M.A., Patarca R., Iregui M.V., and Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol. 147 (1991) 2902-2906
15. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S., and Tarakhovsky A. Immunodeficiency in protein kinase cbeta-deficient mice. Science 273 (1996) 788-791
16. Liaw L., Birk D.E., Ballas C.B., Whitsitt J.S., Davidson J.M., and Hogan B.L. Altered wound healing in mice lacking a functional osteopontin gene (SPP1). J. Clin. Invest. 101 (1998) 1468-1478
17. Mecklenbrauker I., Saijo K., Zheng N.Y., Leitges M., and Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416 (2002) 860-865
18. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., Tsukiyama T., Nagahama H., Ohno S., Hatakeyama S., and Nakayama K.I. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416 (2002) 865-869
19. Nau G.J., Liaw L., Chupp G.L., Berman J.S., Hogan B.L., and Young R.A. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67 (1999) 4223-4230
20. O'Regan A.W., Hayden J.M., and Berman J.S. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J. Leukoc. Biol. 68 (2000) 495-502
21. O'Regan A.W., Nau G.J., Chupp G.L., and Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 21 (2000) 475-478
22. Ohshima S., Yamaguchi N., Nishioka K., Mima T., Ishii T., Umeshita-Sasai M., Kobayashi H., Shimizu M., Katada Y., Wakitani S., Murata N., Nomura S., Matsuno H., Katayama R., Kon S., Inobe M., Uede T., Kawase I., and Saeki Y. Enhanced local production of osteopontin in rheumatoid joints. J. Rheumatol. 29 (2002) 2061-2067
23. Oldberg A., Franzen A., and Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8819-8823
24. Patarca R., Freeman G.J., Singh R.P., Wei F.Y., Durfee T., Blattner F., Regnier D.C., Kozak C.A., Mock B.A., Morse III H.C., et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170 (1989) 145-161
25. Patarca R., Wei F.Y., Singh P., Morasso M.I., and Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4-8-lymphocytes during the development of murine autoimmune disease. J. Exp. Med. 172 (1990) 1177-1183
26. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S.T., and Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374 (1995) 163-165
27. Schneider T.J., Grillot D., Foote L.C., Nunez G.E., and Rothstein T.L. Bcl-x protects primary B cells against Fas-mediated apoptosis. J. Immunol. 159 (1997) 4834-4839
28. Shinohara M.L., Jansson M., Hwang E.S., Werneck M.B., Glimcher L.H., and Cantor H. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 17101-17106
29. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., Teitell M., Leitges M., Kawakami T., and Rawlings D.J. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3 (2002) 780-786
30. Weber G.F., and Cantor H. Differential roles of osteopontin/Eta-1 in early and late lpr disease. Clin. Exp. Immunol. 126 (2001) 578-583
31. Xu G., Nie H., Li N., Zheng W., Zhang D., Feng G., Ni L., Xu R., Hong J., and Zhang J.Z. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J. Clin. Invest. 115 (2005) 1060-1067
32. Yumoto K., Ishijima M., Rittling S.R., Tsuji K., Tsuchiya Y., Kon S., Nifuji A., Uede T., Denhardt D.T., and Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 4556-4561